Amylyx Pharmaceuticals, Inc. (AMLX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

$4.00

south_east -$0.07 (-1.72%)
Day's range
$3.96
Day's range
$4.1

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/18/2024 Robert W. Baird Joel Beatty $11.00 $4.76   131.09%
10/23/2024 Bank of America Securities Geoff Meacham $10.00 $4.53   120.75%
10/18/2024 H.C. Wainwright Andrew Fein $8.00 $3.92   104.08%
10/18/2024 Leerink Partners Marc Goodman $4.00 $3.92   2.04%
05/14/2024 Mizuho Securities Graig Suvannavejh $3.00 $1.82   64.84%
04/11/2024 Robert W. Baird Joel Beatty $3.00 $2.46   21.95%
04/04/2024 Deutsche Bank Neena Bitritto-Garg $4.00 $2.62   52.96%
03/17/2024 Mizuho Securities Graig Suvannavejh $4.00 $3.24   23.46%

Amylyx Pharmaceuticals, Inc. FAQ's

What analysts cover Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. has been rated by research analysts at Robert W. Baird, Bank of America Securities, H.C. Wainwright, Leerink Partners, Mizuho Securities, Deutsche Bank in the past 90 days.